stockrow
Saturday 31 October 2026
Export CME’s income statement to Excel — free account
CME Group Inc.
CME Financial Financial Data & Stock Exchanges
CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
- Revenue
- +0.84%
- EPS
- +2.85%
- Free cash flow
- −11.2%
- Total debt
- +0.11%
Quarter to June 2026, against a year earlier
303.14
6.72
+2.27%
Follow CME
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
18.59 | 25.03 | 24.43 | 26.16 |
+8 more quarters Free account |
P/S ratio |
11.76 | 15.70 | 15.06 | 15.19 | |
P/FCF ratio |
18.91 | 24.51 | 23.42 | 23.80 | |
P/Operating CF |
84.10 | 84.23 | 86.61 | 100.39 | |
P/B ratio |
3.00 | 3.99 | 3.42 | 3.45 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
11.93 | 15.84 | 14.89 | 15.32 | |
EV/EBITDA |
17.04 | 22.47 | 21.29 | 21.84 | |
EV/Operating CF |
18.75 | 24.21 | 22.70 | 23.56 | |
EV/FCF |
19.18 | 24.72 | 23.15 | 24.01 | |
Quick Ratio |
0.02 | 0.02 | 0.03 | 0.02 | |
Current Ratio |
1.02 | 1.02 | 1.03 | 1.02 | |
Net Debt/EBITDA |
0.96 | 0.65 | (1.02) | 0.81 | |
Debt/Assets |
1.76% | 1.69% | 1.72% | 1.83% | |
Debt/Equity |
0.13 | 0.13 | 0.12 | 0.12 | |
Asset Turnover |
0.04 | 0.04 | 0.04 | 0.04 | |
Operating CF/Net income |
0.91 | 1.08 | 0.97 | 1.08 | |
Capex/Depreciation |
(0.28) | (0.26) | (0.39) | (0.22) | |
Interest Coverage |
25.39 | 30.04 | 23.33 | 22.10 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
26.67% | 23.12% | 27.95% | 27.79% | |
Intangible Assets out of Total Assets |
0.16 | 0.15 | 0.15 | 0.16 | |
Share Based Compensation of Revenue |
1.45% | 1.16% | 1.75% | 1.56% | |
Graham Net Nets |
(0.08) | (0.06) | (0.04) | (0.06) | |
Graham Number |
140.19 | 140.24 | 141.75 | 134.97 | |
Earnings Yield |
5.38% | 4.00% | 4.09% | 3.82% | |
Free Cash Flow Yield |
5.29% | 4.08% | 4.27% | 4.20% | |
Revenue per Share |
4.73 | 5.23 | 4.58 | 4.27 | |
Operating CF per Share |
2.63 | 3.51 | 3.15 | 2.69 | |
Capex per Share |
(0.07) | (0.06) | (0.09) | (0.05) | |
Free Cash Flow per Share |
2.56 | 3.45 | 3.06 | 2.64 | |
Cash per Share |
6.31 | 7.00 | 12.63 | 7.15 | |
Shareholders Equity per Share |
73.53 | 74.08 | 79.88 | 78.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
73.53 | 74.08 | 79.88 | 78.37 | |
Free Cash Flow |
923.50 | 1,238.10 | 1,101.40 | 949.70 | |
Working Capital |
2,913.80 | 3,003.40 | 5,062.60 | 3,213.60 | |
Capital Expenditures |
(23.60) | (21.80) | (32.50) | (18.40) | |
Net Current Asset Value |
(6,525.10) | (6,374.10) | (4,336.70) | (6,153.50) | |
EV/EBIT |
18.33 | 24.15 | 22.96 | 23.58 | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.01 | |
Price to Operating Income |
18.07 | 23.95 | 23.22 | 23.38 | |
| Other line items | |||||
Average Receivables |
710.35 | 852.85 | 606.15 | 636.15 | |
Average Payables |
80.15 | 87.80 | 75.85 | 102.40 | |
Average Assets |
187,291.80 | 179,912.55 | 167,935.60 | 162,469.85 | |
Average Common Equity |
27,129.70 | 26,824.45 | 27,607.55 | 28,203.25 |
Columns are period end dates